… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
trial to … Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as …

… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
… Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with remdesivir as com…

… We wanted to know if remdesivir is an effective treatment for people with COVID‐19 and if
it causes unwanted effects compared to placebo or usual care. Its effect could depend on how …

… We searched for studies that investigated remdesivir to treat adults with COVID‐19 compared
to placebo or standard care. Patients were hospitalised with COVID‐19 and could be of …

… with Covid-19–related respiratory disease, these criteria resulted in the use of remdesivir …
Diseases Society of America recommends treatment with a single neuraminidase inhibitor as …

… Optimism surrounding forthcoming results from phase 3 COVID-19 … of remdesivir, but in the
context of other high-quality studies. For now, remdesivir is an important COVID-19 treatment …

… commonly in the standard care treatment group. These agents … in the control vs active treatment
groups. As suggested by the … the remdesivir group to facilitate completion of the treatment …

… ) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we …
the efficacy and safety of remdesivir administration in COVID-19 patients. A systematic literature …

… the use of remdesivir in the treatment of COVID-19 for patients … the completion of the Adaptive
COVID-19 Treatment Trial 1 (… of remdesivir for the treatment of COVID-19 therefore remain …

… Remdesivir has been recently a strong candidate for the treatment of Covid-19. In this
commentary, we have portrayed the structure of the coronavirus in a simple way as well as the site …